<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Zhao X</submitter><funding>Chinese Government Scholarship</funding><funding>National Natural Science Foundation of China</funding><funding>Tsinghua-Toyota Joint Research Institute Inter-Disciplinary Program</funding><pagination>13</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12838086</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>18(1)</volume><pubmed_abstract>The design of neoepitope-based cancer immunotherapy requires predicting the immunogenicity of each patient-specific neoepitope candidate. We designed NeoGuider, a machine-learning model to address nonlinearity and class imbalance in such prediction. Central to NeoGuider is a supervised feature-transformation approach, which estimates odds using our custom kernel density estimation followed by centered isotonic regression. We implemented NeoGuider as a bioinformatics pipeline, which detects neoepitope candidates from sequencing data and prioritizes such candidates by predicted immunogenicity. Benchmarking on 7 cohorts, 113 patients, and 635 immunogenic candidates showed that NeoGuider outperformed existing methods in neoepitope prediction. NeoGuider is open-source at https://github.com/Xueg</pubmed_abstract><journal>Genome medicine</journal><pubmed_title>NeoGuider: neoepitope prediction using advanced feature engineering.</pubmed_title><pmcid>PMC12838086</pmcid><funding_grant_id>62373210</funding_grant_id><funding_grant_id>20243930093</funding_grant_id><funding_grant_id>2022GXZ005806</funding_grant_id><funding_grant_id>92470105</funding_grant_id><pubmed_authors>Xie Z</pubmed_authors><pubmed_authors>Zhang X</pubmed_authors><pubmed_authors>Wei L</pubmed_authors><pubmed_authors>Zhao X</pubmed_authors></additional><is_claimable>false</is_claimable><name>NeoGuider: neoepitope prediction using advanced feature engineering.</name><description>The design of neoepitope-based cancer immunotherapy requires predicting the immunogenicity of each patient-specific neoepitope candidate. We designed NeoGuider, a machine-learning model to address nonlinearity and class imbalance in such prediction. Central to NeoGuider is a supervised feature-transformation approach, which estimates odds using our custom kernel density estimation followed by centered isotonic regression. We implemented NeoGuider as a bioinformatics pipeline, which detects neoepitope candidates from sequencing data and prioritizes such candidates by predicted immunogenicity. Benchmarking on 7 cohorts, 113 patients, and 635 immunogenic candidates showed that NeoGuider outperformed existing methods in neoepitope prediction. NeoGuider is open-source at https://github.com/Xueg</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Dec</publication><modification>2026-06-11T05:34:33.756Z</modification><creation>2026-06-11T03:08:24.772Z</creation></dates><accession>S-EPMC12838086</accession><cross_references><pubmed>41437280</pubmed><doi>10.1186/s13073-025-01592-9</doi></cross_references></HashMap>